Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 5
Submit an article Journal homepage
143
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis

Leiv Ose Lipid Clinic, Medical Department, Rikshospitalet, Oslo, NorwayCorrespondence[email protected]
,
Arvind Shah Merck Research Laboratories, Rahway, NJ, USA
,
Michael J. Davies Merck Research Laboratories, Rahway, NJ, USA
,
Jennifer Rotonda Merck Research Laboratories, Rahway, NJ, USA
,
Darbie Maccubbin Merck Research Laboratories, Rahway, NJ, USA
,
Diane Tribble Merck Research Laboratories, Rahway, NJ, USA
,
Enrico Veltri Schering-Plough Research Institute, Kenilworth, NJ, USA
&
Yale Mitchel Merck Research Laboratories, Rahway, NJ, USA
 show all
Pages 823-835 | Accepted 24 Feb 2006, Published online: 23 Mar 2006

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Alberico Catapano, Peter P Toth, Joanne E Tomassini & Andrew M Tershakovec. (2013) The efficacy and safety of ezetimibe coadministered with statin therapy in various patient groups. Clinical Lipidology 8:1, pages 13-41.
Read now
Nkechinyere Ijioma & Jennifer G Robinson. (2011) Lipid-lowering effects of ezetimibe and simvastatin in combination. Expert Review of Cardiovascular Therapy 9:2, pages 131-145.
Read now
Steven Hildemann, Barbara Karmann, David Pittrow, Christian Barho, Harald Darius & Christoph Bode. (2008) Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care. Current Medical Research and Opinion 24:6, pages 1659-1668.
Read now
Kosmas I. Paraskevas & Dimitri P. Mikhailidis. (2008) C-reactive protein (CRP): more than just an innocent bystander?. Current Medical Research and Opinion 24:1, pages 75-78.
Read now
D. P. Mikhailidis, G. C. Sibbring, C. M. Ballantyne, G. M. Davies & A. L. Catapano. (2007) Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Current Medical Research and Opinion 23:8, pages 2009-2026.
Read now
Steven K. Hildemann, Christian Barho, Barbara Karmann, Harald Darius & Kurt Bestehorn. (2007) Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice. Current Medical Research and Opinion 23:4, pages 713-719.
Read now
Irene F Gazi & Dimitri P Mikhailidis. (2006) Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview. Expert Opinion on Therapeutic Targets 10:6, pages 851-866.
Read now
Stella S. Daskalopoulou & Dimitri P. Mikhailidis. (2006) Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia. Current Medical Research and Opinion 22:10, pages 2037-2039.
Read now

Articles from other publishers (11)

Juan Tamargo, Niti R. Aggarwal & María Tamargo. 2021. Sex Differences in Cardiac Diseases. Sex Differences in Cardiac Diseases 597 642 .
Isa Naina Mohamed, Peter J. Helms & James S. McLay. (2012) Using Primary Care Prescribing Databases to Determine Drug Switching and Continuation of Care. Basic & Clinical Pharmacology & Toxicology 111:6, pages 396-401.
Crossref
Erina ShigematsuTadashi YamakawaMasataka TaguriSatoshi MoritaMikiya TokuiKazunori MiyamotoOsamu FunaeYoji TakatukaKazuaki KadonosonoHiroshi ShigematsuYasuo Terauchi. (2012) Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis 19:9, pages 846-853.
Crossref
H. Robert Superko, Kathryn M. Momary & Yonghong Li. (2012) Statins Personalized. Medical Clinics of North America 96:1, pages 123-139.
Crossref
A. S. Wierzbicki. (2011) The ezetimibe Jonah: the trials and tribulations of an unlucky drug. International Journal of Clinical Practice 65:12, pages 1207-1208.
Crossref
Harold E. Bays, Scott E. Conard, Lawrence A. Leiter, Steven R. Bird, Robert S. Lowe & Andrew M. Tershakovec. (2011) Influence of age, gender, and race on the efficacy of adding ezetimibe to atorvastatin vs. atorvastatin up-titration in patients at moderately high or high risk for coronary heart disease. International Journal of Cardiology 153:2, pages 141-147.
Crossref
Hyung Sik Yoon, Sung Ho Kim, Jeong Kyung Kim, Sang Hun Ko, Jae Ee Ko, Soo Jin Park, Moon Gi Park, Jae Hwan Lee & Min Soo Hyon. (2011) Comparison of Effects of Morning Versus Evening Administration of Ezetimibe/Simvastatin on Serum Cholesterol in Patients with Primary Hypercholesterolemia. Annals of Pharmacotherapy 45:7-8, pages 841-849.
Crossref
Isa Naina Mohamed, Peter J. Helms, Colin R. Simpson & James S. McLay. (2011) Using Routinely Collected Prescribing Data to Determine Drug Persistence for the Purpose of Pharmacovigilance. The Journal of Clinical Pharmacology 51:2, pages 279-284.
Crossref
Piers R. Blackett, Petar Alaupovic, Kevin Short & Kenneth C. Copeland. 2011. Management of Pediatric Obesity and Diabetes. Management of Pediatric Obesity and Diabetes 101 140 .
Adam B. PolisM.A.M.A., Nicola AbateM.A.M.A., Alberico L. CatapanoPh.D.Ph.D., Christie M. BallantyneM.D.M.D., Michael H. DavidsonM.D.M.D., Steven S. SmugarM.D.M.D. & Andrew M. TershakovecM.D., M.P.M.D., M.P.. (2009) Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified by National Cholesterol Education Program Risk Category. Metabolic Syndrome and Related Disorders 7:6, pages 601-610.
Crossref
J. P. D. Reckless, P. Henry, T. Pomykaj, S. T. Lim, R. Massaad, K. Vandormael, A. O. Johnson-Levonas, K. Lis, P. Brudi & C. Allen. (2008) Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study. International Journal of Clinical Practice 62:4, pages 539-554.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.